Iovance Biotherapeutics (IOVA) announced that Dan Kirby will join the Company’s executive leadership team in the newly created role of Chief Commercial Officer, effective today. Prior to joining Iovance, Kirby led global commercial strategy for an emerging cell therapy platform of products as Chief Commercial Officer of Orca Bio.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.